ElevateBio Raises $525M in Series C Financing

16 Mar, 2021

ElevateBio Raises $525M in Series C Financing
Photo by Vincent Garnier on Unsplash

– ElevateBio is a Cambridge, Mass.-based cell and gene therapy technology company focused on advancing new cell and gene therapies.
– Company raised $525m in Series C funding.
– The round was led by Matrix Capital Management with participation from new investors SoftBank Vision Fund 2 and Fidelity Management and Research Company and existing investors MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group, Emerson Collective, Surveyor Capital (A Citadel company), EDBI, and Vertex Ventures, iTochu, and a large insurance company.

Biotechnology Genetics Health Care North America Therapeutics Wellness
Crunchbase icon

Content report

The following text will be sent to our editors: